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Abstract
Background: The prevalence of infections by nontuberculous mycobacteria (NTM) has steadily increased over the
past decades, especially in immunocompromised patients.
Case presentation: We present a patient with IgA-deficiency and mixed cutaneous infection by two slowly
growing mycobacteria, Mycobacterium (M.) haemophilum and M. kansasii.
Conclusions: Cutaneous M. haemophilum infections most often result from HIV or transplantation-associated
immunosuppression. Rarely, M. haemophilum may also infect healthy patients or iatrogenically immunosuppressed
patients without transplantation. M. kansasii is one of the most frequent NTM and large awareness exists about its
involvement in human diseases. Mycobacterial diagnosis of cutaneous infections should be considered in long-
lasting skin lesions.
Background
Immunoglobulin (Ig) A-deficiency is the most common
primary antibody deficiency. Although the majority of
affected individuals have no apparent symptoms,
selected patients suffer from recurrent mucosal infec-
tions, allergies, and autoimmune diseases [1]. So far, in
patients with selective IgA deficiency no infections with
nontuberculous mycobacteria (NTM) have been
reported. However, in the last decade NTM are increas-
ingly recognized as infective agents, particularly among
immunocompromised patients.
Mycobacterium haemophilum is an established cause
of cutaneous infections in immunocompromised
hosts [2]. The most common clinical manifestation of
M. haemophilum infections are skin lesions with a pre-
ference for cooler body sites such as extremeties, while
the development of sporotrichoid-like nodular lymphan-
gitis is exceptional.
M. kansasii is one of the most frequent NTM causing
human diseases among both immunocompetent and
immunocompromised patients [3]. M. kansasii most
likely causes infections resembling tuberculosis likewise
with a preference for pulmonary disease [4]. Cutaneous
infections due to this slow growing mycobacterium are
rare and may resemble cellulitis or sporotrichosis.
Nevertheless, M. kansasii should be included in the dif-
ferential diagnosis of skin infections with an indolent
course and lack of response to standard antibiotics [5].
Since NTM are typically ubiquitous in the natural envir-
onment several routes of transmission may be consid-
ered [3]. Unfortunately, the environmental source of
M. haemophilum is still unknown, while tap water is
likely the major reservoir for M. kansasii infections.
Inoculation of NTM into the host usually occurs due to
impairment of the physical skin barrier. Affected patients
commonly show a history of fish tank cleaning, oyster
shucking, swimming, or other aquatic activities [6].
Case presentation
A 48-year old man presented with multifocal nodules of
variable size arranged in a sporotrichoid-like manner on
the right arm, the dorsum of the digit IV, the left arm,
the right side of his back, the knees and a partly circum-
scribed erythematous plaque on his back (Figure 1A-D).
The lesions persisted for already 2 months without any
other symptoms.
* Correspondence: vbek777@gmail.com
1Department of Dermatology and Allergology, Ludwig-Maximilians-
University, Munich, Germany
Full list of author information is available at the end of the article
Bekou et al. BMC Dermatology 2011, 11:3
http://www.biomedcentral.com/1471-5945/11/3
© 2011 Bekou et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.B
A
D
C
F
E
Figure 1 Clinical and histological findings. On the right arm (A) erythematous nodules (B) were found in a sporotrichoid-like manner. At the
back (C) a sharply marginated erythematous plaque (D) was seen. The histopathology of the skin revealed in the dermis disseminated caseating
partly epitheloid cell granulomas with a marginal zone of lymphocytes and a subepidermal lymphohistiocytic infiltrate with perivascular
accentuation (E). Close up of an epitheloid cell granuloma (F).
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(dorsum of right digit IV, dorsum of the right hand, the
right elbow, and the patients back) were initiated and
subjected in parallel to histopathological and microbio-
logical examinations. They revealed caseating epitheloid
cell granuloma in the dermis with a marginal zone of
lymphocytes and a subepidermal lymphohistiocytic infil-
trate with perivascular accentuation (Figure 1E, F). By
PAS-, Fite-, Ziehl-Neelsen and Auramin staining no acid
fast bacilli were detected. Borrelia-specific IgM and IgG
and tuberkulin skin test were negative. Microbiological
cultures showed twice growth of M. haemophilum from
independent lesions on the right hand taken about 8
weeks apart. Interestingly, M. kansasii was recovered
from another lesion on the right elbow indicating a
mixed infection.
Mycobacteria-specific liquid and solid cultures were
performed by using the automated BACTEC MGIT 960
system (Becton Dickinson)a t3 6 ° Ca n dL o w e n s t e i n -
Jensen Agar (LJA) at 24°C, 30°C, and 36°C. Growth of
acid fast bacilli was detected from LJA at 30°C supple-
mented with hemin discs. First, culture isolates were
identified as NTM due to the absence of an amplicon
by a M. tuberculosis-specific gyrB PCR [7] and were
then further verified by the GenoType Mycobacterium
DNA strip technology (Hain Lifescience, Nehren, Ger-
many), namely the GenoType Mycobacterium CM and
AS assay (CM, common mycobacteria; AS, additional
species) [8]. The GenoType Mycobacterium CM assay
enables the simultaneous identification of several spe-
cies, including those of the M. tuberculosis complex, the
M. avium complex, M. abscessus, M. kansasii and
M. chelonae etc. The Mycobacterium AS test provides
the identification of rarely found species, such as
M. simiae, M. haemophilum,a n dM. mucogenicum.I n
case of M. haemophilum, Mycobacterium CM assay
revealed a banding pattern specific for the M. haemophi-
lum-M. nebraskense-M. malmoense-M. palustre group.
Further species differentiation was done with the AS assay
that showed positivity for M. haemophilum and
M. nebraskense but not for M. malmoense or M. palustre.
The growth requirement for hemin indicated the presence
of M. haemophilum. Nevertheless, species identification of
M. haemophilum was confirmed at the National Reference
Center for Mycobacteria in Borstel (Germany). M. kansasii
was recovered with the Bactec MGIT 960 and identified
with the GenoType Mycobacterium CM assay.
Thus, culture positive lesions were all from the right
body site, while no co-infection of a single lesion was
found. Interestingly, the patient was working as a scaf-
folder having potential exposure to diverse environmen-
tal habitats while touring around Europe. Further, he is
aquarist but reports to usually wear gloves during clean-
ing his aquarium.
Interestingly, in the patient’s history a selective IgA-
deficiency was documented since childhood. His mother
also suffered from IgA-deficiency. Since infancy human
immunoglobulin (Beriglobin
®) was administered, but
due to his frequent travel activities the substitution was
realized irregularly. Serum IgA level was 1.8 (07-4.0)
mg/ml under substitution with Beriglobin
®. Biochemical
laboratory parameters were within normal ranges except
for serum protein electrophoresis with albumin of 57.2%
(59-70.6) and beta globulin of 14.9% (7.3-12.2). ASL,
AST, ACE, ANA, and ENA tests were unremarkable.
Besides multiple cutaneous lesions there was no evi-
dence for lymphadenopathy or systemic infection with
M. haemophilum/M. kansasii by using abdominal ultra-
sound, thorax X-ray, and thoraco-abdominal computer
tomography imaging. Mycobacterial sputum cultures
were negative as well. Empirical triple treatment with
clarithromycine 2 × 500 mg/d, rifabutine 1 × 300 mg/d
and ethambutol 1 × 20 mg/kg body weight/d was
initiated. This regime was given for 6 months, while a
complete clinical remissiono fs k i nl e s i o n sw a ss e e n
within 4 months. Finally, two years after his initial pre-
sentation the patient is still healthy.
Discussion
NTM can be categorized by the growth rate in slowly
growing and rapidly growing species, pigmentation (pig-
mented and non-pigmented species), and optimal
growth temperature, which can provide helpful informa-
tion for a preliminary classification of NTM. M. mari-
num, M. kansasii,a n dM. avium-intracellulare are
examples of slow-growing mycobacteria. M. fortuitum,
M. chelonea, and M. abscessus are examples of rapidly
growing mycobacteria [1,2]. Diagnosis relies on skin
biopsy, histopathologic examination, microbiological cul-
ture and molecular detection of mycobacterial DNA.
Strikingly, cutaneous M. haemophilum infections are
most often the result of HIV- or transplantation-
associated immunosuppression. It’s most common clinical
manifestations are cutaneous lesions with a preference for
cooler body sites such as extremities. Therefore, in case of
skin biopsies LJA at 30°C should routinely supplemented
with hemin discs in order to fulfill special growth require-
ments of M. haemophilum that is known to primarily
cause cutaneous infections. Rarely, M. haemophilum may
infect iatrogenically immunosuppressed patients without
transplantation or even healthy persons. The development
of sporotrichoid nodular lymphangitis due to M. haemo-
philum is exceptional [3].
In contrast, M. kansasii infection has been reported in
up to 20 percent of nontuberculous mycobacteriosis in
both immunocompetent and immunocompromised
patients. Disseminated infections are uncommon but
of poor prognosis [9]. The outcome of M. kansasii
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early. In one report, M. kansasii cutaneous infection
occurred on the hand and forearm, with carpal tunnel
syndrome complicated by concomitant pulmonary
M. tuberculosis [6], and in another as cellulitis in a
patient with systemic lupus erythematosus [4].
As the only comorbid condition our patient showed
IgA-deficiency. Sustained, very low levels of IgA, IgG, or
IgM, as found in primary immunodeficiency syndromes,
are associated with significantly increased risk for infec-
tions, primarily respiratory tract infections of bacterial
origin. IgA, a major serum Ig and the predominant anti-
body in external secretions that bathe mucosal surfaces,
plays a key role in immune protection. IgA at concen-
trations of about 2-3 mg/ml is the second most preva-
lent serum antibody after IgG, which is normally
present at about 12 mg/ml. However, IgA-deficiency is
the most common primary antibody deficiency and
appears to be well tolerated. Due to the large surface
area of the human mucosa of up to 400 m
2,t h er o l eo f
IgA in the protection of this surface from harmful envir-
onmental agents is extremely essential. Any changes
connected with a lack or an overproduction of IgA can
manifest as variable clinical disease [10]. Most indivi-
duals with IgA-deficiency have no apparent symptoms,
but selected patients suffer from recurrent mucosal
infections, allergies, and autoimmune diseases [1].
Obviously, this biological diversity has both genetic and
environmental components. For instance, it is known
that IgA is secreted with sweat (sIgA) assuming an
important immunological function on skin. Moreover,
lower cutaneous sIgA levels and increased skin infec-
tions have been reported in patients with atopic derma-
titis, while these patients of course often present also an
impairment of the normal skin barrier. In conclusion,
there are some clues about an association of skin infec-
tions with IgA-deficiency, although no clear pathophy-
siological link may be provided [11-13]. Strikingly, there
is increasing evidence that serum IgA is able to trigger
effector functions that have the potential to destroy
microorganisms and mammalian cells. It has long been
recognized that compared with IgM and IgG, IgA is a
poor activator of complement. IgA does not activate the
classical pathway and its role in activation of the alter-
native pathway remains controversial [14]. However, it
m a yh a v ear o l ei na c t i v a t i o no fp h a g o c y t i cs y s t e mb y
means of the FcRa receptors. It has been proposed that
serum IgA binds to FcRa receptor on the monocytes
and granulocytes; thereby, immune complexes formed
by foreign antigens and IgA are cleared from the circu-
lation by the phagocytic system without activating the
complement system and without causing inflammation.
Serum IgA may also have a role in controlling the
immune system through inhibition of neutrophil
chemotaxis by binding to other inhibitory proteins such
as a-1-antitrypsin and forming complexes. Bacteria of
the intestinal tract, oral cavity, and respiratory and geni-
tal tracts are coated with secretory IgA. As a result, the
epithelial adherence and penetration of bacteria are lim-
ited, and the bacteria are confined to the mucosal sur-
faces [15]. Rodriguez et al. suggest that IgA may play a
role in protection against mycobacterial infections in the
respiratory tract by blocking the pathogen entrance and/
or by modulating the pro-inflammatory responses [16].
Most likely, in our patient NTM’s are transmitted
from a contaminated environmental source by a direct
cutaneous route. The exact source and the infection
mode remain unclear. Nevertheless, even in a healthy
individual an appropriate exposition (e.g. skin injury,
“high” bacterial burden) may lead to NTM infections, as
described for M. marinum. In IgA-deficiency, beside
reduced serum IgA levels often also other immune defi-
ciencies e.g. in cytokine levels and B-cell function but
also associated T cell defects have been described. Thus,
we cannot exclude that IgA-deficiency may be a surro-
gate for another undetected less marked immune dys-
function [12].
Conclusions
This is the first report of a mixed cutaneous infection
M. haemophilum and M. kansasii, both belonging to the
slow growing mycobacteria, in a patient with IgA-
deficiency. The patient is aquarist and was working as a
scaffolder presenting a relevant risk of exposure to
diverse environmental habitats while touring around
Europe. Although according to current knowledge no
definite pathophysiological link between mycobacterial
disease and IgA-deficiency may be given, we cannot rule
out that this immunological imbalance may contribute
to the patient’s vulnerability towards NTM. Finally, the
patient responded well to triple anti-mycobacterial ther-
apy with complete regression of entire skin lesions
within 4 months.
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